Cargando…
Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
Recently, adaptive NK cell therapy has become a promising treatment but has limited efficacy as a monotherapy. The identification of immune checkpoint inhibitor (ICI) molecules has opened a new horizon of immunotherapy. Herein, we aimed to demonstrate the cytotoxic effects of a polytherapy consistin...
Autores principales: | Abdolahi, Shahrokh, Ghazvinian, Zeinab, Muhammadnejad, Samad, Ahmadvand, Mohammad, Aghdaei, Hamid Asadzadeh, Ebrahimi-Barough, Somayeh, Ai, Jafar, Zali, Mohammad Reza, Verdi, Javad, Baghaei, Kaveh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473695/ https://www.ncbi.nlm.nih.gov/pubmed/34588986 http://dx.doi.org/10.3389/fphar.2021.733075 |
Ejemplares similares
-
Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model
por: Ghazvinian, Zeinab, et al.
Publicado: (2023) -
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022) -
Contribution of natural killer cells in innate immunity against colorectal cancer
por: Ghazvinian, Zeinab, et al.
Publicado: (2023) -
Angiogenesis and Its Targeting in Glioblastoma with Focus
on Clinical Approaches
por: Daneshimehr, Fatemeh, et al.
Publicado: (2022) -
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2019)